Discover. Connect. Capitalize.

Expert View

131 Profile Views - 679 Project Views

Share

John Reid Wingard
Price Eminent Scholar, Deputy Director of Research & Director of Bone Marrow Transplant Program

University of Florida

Connect

Search

Google or Google Scholar for John Wingard

Begin Date End Date Title
12-16-2019 12-15-2024 1705
05-31-2019 05-30-2024 BMT CTN 1703/1801
05-28-2019 05-27-2024 CTRL-ALT-D
05-24-2019 05-23-2024 BMTCTN1704
09-27-2018 07-31-2021 Self-Management of Psychoneurological Symptoms in HCT Su
10-26-2017 10-25-2022 BMT CTN1502
08-29-2017 08-28-2022 EA4151
07-27-2017 06-30-2024 Wingard - BMT CTN Renewal
03-24-2017 03-23-2022 Miscellaneous Donors Project
09-30-2016 09-29-2021 BMT CTN 1501
07-06-2016 07-05-2023 A051301/BMT CTN 1201
10-19-2015 05-31-2017 A Randomized Recruitment Intervention Trial
09-15-2015 02-15-2022 Easy-to-Read Informed Consent (ETRIC) for Hematopoietic
05-21-2015 05-20-2018 Randomized study of individualized care plans
05-01-2015 04-30-2016 BMT CTN LTFU
04-01-2015 03-31-2021 BMT CTN 1301
07-01-2014 06-30-2019 Clinical Study Protocol Rider #1203
05-14-2014 05-13-2019 CTN1102: A Multi-Center Biologic Assignment Trial Compa
09-01-2013 09-30-2016 Individualized Care Plans for Hematopoietic Cell Transpl
07-01-2013 12-31-2019 Re-MATCH
05-01-2013 04-30-2020 Proposal 1202: Prospective Multi-Center Cohort for the
08-01-2012 07-01-2016 Phase II Study of Combination of Hyper-CVAD and D
04-01-2012 03-31-2021 PROTOCOL 1101 A Multi-Center, Phase III, Randomized
08-08-2011 06-30-2017 Core Clinical Consortium for Blood and Marrow Transplant..
03-29-2011 06-28-2012 Protocol 09-SQOL: Pilot study to assess the feasibility
12-29-2010 12-31-2019 Protocol 0804: A Phase II study of reduced-intensity all
12-29-2010 04-06-2016 Protocol 0901: A Randomized, Multi-Center, Phase III Stu
10-20-2010 10-18-2017 F014160: Support Teaching and Research Programs at UF
09-15-2010 11-19-2012 A Phase III Randomized, Multicenter Trial Testing Whethe
09-03-2010 08-02-2016 Protocol 0803: High Dose Chemotherapy with Autologous
08-04-2010 08-04-2015 A Research Database for the Hematopietic Stem Cell Trans
07-01-2010 06-30-2019 F002418: Support ESC devoted to Cancer Research,
04-29-2010 04-29-2016 Protocol#0702 A Trial of Single AutologousTransplant
02-03-2010 02-03-2022 Protocol 0801: A Phase II/III Randomized, Multicenter Tr
02-03-2010 02-17-2016 Protocol 0802: A Multi-Center, Randomized, Double Blind,
06-04-2009 06-04-2015 Protocol 0701: A Phase II Trial of Non-Myeloablative All
08-13-2008 06-01-2012 Protocol 0603: A Multi-Center, Phase II Trial of Nonmyel
08-13-2008 06-01-2012 Protocol 0604: A Multi-Center, Phase II Trial of Non-Mye
06-01-2008 05-31-2010 Mycology Research Unit; In Vivo Induced Fungal Antigens
05-20-2008 05-20-2017 Protocol #0703: A Phase II Study of Tandem Autologous
01-01-2008 05-31-2009 Mycology Research Unit: In ViVO Induced Fungal Antigens
07-01-2007 06-30-2019 Umbilical Cord Research
05-30-2007 02-29-2016 Clinical Laboratory Diagnostics for Invasive Aspergillos
03-08-2007 11-30-2008 Sample Collection, Processing and Clinical Trials - LUPR
02-22-2007 02-22-2019 Protocol 0502: A Phase II Study of Allogenic Transplant
02-22-2007 02-22-2016 Protocol 0402 ...Comparing sirolimus/tacrolimus with...
02-22-2007 02-22-2016 Protocol 0501: Multi-center, Open Label, Randomized Tria
01-01-2007 02-29-2012 UFCC for Cardiovascular Cell Therapy Research Network
12-01-2006 12-01-2015 Protocol # 0201: A Phase III Randomized, Multicenter Stu
12-01-2006 12-01-2015 Protocol #0401: Phase III Rituxan/BEAM vs. Bexxar/BEAM
12-01-2006 11-07-2012 Protocol # 0102: A Trial of Tandem Autologous Stem Cell
12-01-2006 08-18-2012 Protocol 0403: A Phase III, Randomized Double-Blind, Pla
09-29-2006 07-31-2007 NHLBI Blood and Marrow Transplant Clinical Research Netw
02-15-2006 08-06-2009 T00008 Renal Cell Carcinoma
09-01-2005 09-28-2006 CORE CLINICAL CENTER FOR BMT CLINICAL RESEARCH NETWORK
04-25-2005 02-15-2010 Protocol #0302 Initial systemic treatment of acute GVHD
11-15-2004 02-15-2008 OPEN-LABEL, LIMITED ACCESS PROTOCOL OF POSACONAZOLE IN
09-01-2004 08-31-2005 CORE CLINICAL CENTER FOR BMT CLINICAL RESEARCH NETWORK
06-15-2004 12-31-2007 MYCOLOGY RESEARCH UNIT: IN VIVO INDUCED FUNGAL ANTIGENS
04-06-2004 06-18-2008 MMF - FHCRC 1697
01-08-2004 08-31-2006 PATIENT COSTS - CLINICAL CENTER FOR BMT CLINICAL RESEAR
08-13-2003 05-23-2009 UFRF MISCELLANEOUS
08-04-2003 11-13-2003 A PROSPECTIVE RNDMZD DBL-BL MULTI-CTR PILOT STUDY OF THE
01-01-2003 12-31-2005 UNEXAMINED ISSUES FOR SURVIVORS and THEIR SPOUSES AFTER BL
07-01-2002 10-03-2003 IV BULSULFAN:ONCE DAILY INTRAVENOUS BULSULFAN (BULSULFEX
07-01-2002 06-14-2003 MULTICTR DBL-BL RNDMZD COMPAR STDY TO EVAL THE SAFETY TO
06-01-2002 05-31-2003 ENHANCING RECOVERY FROM BONE-MARROW TRANSPLANT
01-01-2002 09-29-2006 CDC PA 00055: SURVEILLANCE OF INVASIVE FUNGAL INFECTION
12-13-2001 12-13-2006 HEMATOLOGY/ONCOLOGY PRECEPTORSHIPS
11-14-2001 01-03-2004 A RETROSPECTIVE STUDY TO ESTABLISH AN HISTORICAL DATABAS
09-30-2001 08-31-2004 CORE CLINICAL CENTER FOR BMT CLINICAL RESEARCH NETWORK
09-25-2001 09-30-2008 VALGANCICLOVIR FOR THE PREVENTION OF LATE CMV INFECTION
08-23-2001 08-23-2004 FELLOWSHIP SUPPORT
10-03-2000 06-30-2002 IV BULSULFAN:ONCE DAILY INTRAVENOUS BULSULFAN (BULSULFEX
05-19-2000 05-18-2001 INDEPENDENT MEDICAL EDUCATION PROGRAM
04-28-2000 06-30-2002 MULTICTR DBL-BL RNDMZD COMPAR STDY TO EVAL THE SAFETY TO
04-06-2000 06-30-2005 EVAL OF DRUG INTERAC BTWN ORAL ITRACONZOLE and ORAL TACRO-
04-06-2000 06-14-2005 EVAL OF DRUG INTERACTION BTWN IV INTRCONAZOLE and CYCLOSPO
04-04-2000 11-21-2003 P00041 - OPEN-LABEL TREATMENT PROTOCOL FOR THE SAFETY and
01-19-2000 04-21-2002 EVALUATION OF THE BAXTER OPTIPRESS(TM)II IN THE SEPARATI
12-29-1999 10-20-2000 CHIMERIC 3- A MULTI-CTR, OPN-LBL RNDMZD ACTIVE CONTROLLE
09-01-1999 08-16-2002 ISOLEX 92004 302302-PERIPHERAL BLOOD STEM CELL TRANSPLAN
09-01-1999 08-27-2001 FK463-A PHASE 111 RNDMZD DBL-BL COMPARATIVE TRIAL OF FK4
08-09-1999 07-21-2001 A MULTICENTER PROSPECTIVE STUDY TO EVALUATE THE COSTS OF
07-16-1999 03-31-2001 GEN-HER-2-NEU - AUTOTRANSPLANTATION AND HER2 NEU ANTIBOD
07-05-1999 12-31-1999 PR96-22-022 RANDOMIZED STUDY OF PROCRIT (EPOETIN ALFA) I
07-01-1999 06-30-2003 QUALITY OF LIFE AND RELATIONSHIPS AFTER BMT
06-15-1999 04-03-2001 EFFICACY, SAFETY AND TOLERATION OF VORICONAZOLE VERSUS
04-08-1999 03-29-2001 A PHASE III OPN-LBL MULIT-CTR RNDOMZD COMPARATIVESTUDY O
02-25-1999 12-15-2000 A PILOT STUDY OF ALLOGENEIC BONE MARROW TRANSPLANTATION
10-21-1998 01-10-2001 DATA MANAGEMENT GRANT AGREEMENT
10-15-1998 02-16-2001 STUDY OF MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS BY
07-01-1998 06-30-2010 HEMATOLOGY/ONCOLOGY FELLOWSHIP SUPPORT
02-24-1998 12-31-2000 RANDOMIZED, OPEN-LABEL COMPARATIVE MULTICENTER TRIAL OF
12-23-1997 11-15-1998 A PHASE I/II TRIAL TO DETERMINE THE OPTIMAL DOSE OF SC-7
08-28-1997 02-02-2001 A NONMYELOABLATIVE CONDITIONING REGIMEN OF INTENSIVE IMM
08-01-1997 07-31-1999 RNDMZD DBL-BL COMPAR TRL OF AMBISOME VS ABELCET IN THE
07-01-1997 01-31-2000 PROPHYLACTIC PLATELET TRANSFUSION IN HEMATOPOIETIC STEM
07-01-1997 06-30-1998 HEMATOLOGY/ONCOLOGY FELLOWSHIP SUPPORT
06-03-1997 03-01-1999 PHASE II/III RNDMZD, DBL-BL, PLCB-CNTRL TRL OF RECOMBINA
04-01-1997 02-22-2002 CTI 1034-A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-
01-31-1997 10-07-2000 PLACEBO-CONTROLLED TRIAL OF LISOFYLLINE IN HIGH RISK
10-15-1996 04-30-2001 PHASE I/II TRIAL TO DETERMINE THE MAXIMUM TOLERATED DOSE
10-14-1996 07-20-2001 ORPHAN MEDICAL, INC., PROTOCOL OMC-BUS-3 AND OMC-BUS 4 (
09-01-1996 08-30-2000 CLINICAL STUDY SUPPORT PERSONNEL AGREEMENT

© 1999-2023, State of Florida